Daihan Pharmaceutical Co.,Ltd. (023910.KQ)
ValueMarkers Composite Index
78% below intrinsic value ($91)
Daihan Pharmaceutical Co.,Ltd. (023910.KQ) — VMCI valuation read
Across 120 indicators, Daihan Pharmaceutical Co.,Ltd. (023910.KQ) lands at VMCI 66/100. The Healthcare sector median is 50, so the 16-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.
No material Form 4 disclosures landed on 023910.KQ in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.
**Investor frame.** On Value, 023910.KQ trades at 15.0x earnings, 17% below the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of 1.1x leaves covenant headroom for 023910.KQ on the trailing balance sheet.
023910.KQ fell 1.7% over the trailing 7 days, with a -9.4% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.